Search Results

Site Search

Facebook

Facebook Email or phone Password...

Facebook

Facebook Email or phone Password...

Facebook

Facebook Email or phone Password...

Facebook

Facebook Email or phone Password...

Dangerous Goods Training Has Moved - Insights

Update your bookmark! Dangerous Goods can now be found at https://news.mayocliniclabs.com/dangerous-goods-training/

MCL Viral Susceptibility Lymphoproliferation and Hemophagocytic Lymphohistiocytosis Patient Information MC1235304

MCL Viral Susceptibility Lymphoproliferation Hemophagocytic Lymphohistiocytosis Patient Information Complete print Reset Form Viral Susceptibility Lymphoproliferation Hemophagocytic Lymphohistiocytosis Patient Information Instructions...

Global capabilities - Insights

Check out how Mayo Clinic Laboratories optimized global capabilities facilitate individualized solutions that ensure international clients receive expeditious, accurate answers.

Kelch-like protein 11 autoantibodies: A novel biomarker of testicular cancer associated neurological autoimmunity - Insights

This “Specialty Testing” webinar will discuss the collaborative effort which led to the discovery of Kelch like protein 11 (KLHL11) IgG as a specific biomarker of neurological autoimmunity associated testicular germ cell tumor.

Cytology: A compelling molecular testing approach - Insights

Learn more about how Mayo Clinic Laboratories is advancing the use of cytology specimens for solid tumor next-generation sequencing.

Precision therapeutics - Insights

At Mayo Clinic Laboratories, utilization of precision therapeutics, or pharmacogenomic testing used in conjunction with therapeutic drug monitoring, provides personalized insights to guide and monitor prescription medication use.